3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
14
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Rectal Neoplasms
45
Colorectal Neoplasms
45
Esophageal Neoplasms
28
Esophageal Squamous Cell Carcinoma
24
Stomach Neoplasms
22
Pancreatic Neoplasms
19
Colonic Neoplasms
18
Adenocarcinoma Of Esophagus
15
Carcinoma, Hepatocellular
14
Neoplasm Metastasis
7
Liver Neoplasms
6
Cholangiocarcinoma
5
Recurrence
4
Locally Advanced Rectal Cancer
4
Turcot syndrome
3
Peritoneal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Breast Neoplasms
2
Bites and Stings
2
Adenocarcinoma
2
Surgery
1
Successful Conversion Rate of Operation
1
Radiation Injuries
1
QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Ductal Adenocarcinoma
1
Interventions
pembrolizumab
29
Cetuximab
11
Nivolumab
10
Fluorouracil
8
Cyclophosphamide
8
Cisplatin
8
Carboplatin
8
fludarabine
7
atezolizumab
7
Blood Specimen Collection
7
cemiplimab
6
Radiotherapy
6
Drug Therapy
6
Immune Checkpoint Inhibitors
5
Gemcitabine
5
Paclitaxel
4
Docetaxel
4
Capecitabine
4
Biopsy
4
spartalizumab
3
avelumab
3
Surveys and Questionnaires
3
Pemetrexed
3
Oncolytic Virotherapy
3
Nicotine
3
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Ipilimumab
3
Interleukin-2
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Neoadjuvant Therapy
×
Gastrointestinal
×
Clear all
NCT03323424
2020-01-30
IRAM
Institut de Cancérologie de la Loire
Phase 2
Withdrawn